ArticleAmerican health & drug benefits2015

Zykadia (Ceritinib) Approved for Patients with Crizotinib-Resistant ALK -Positive Non-Small-Cell Lung Cancer.

Lisa A RaedlerPubMed ↗Full text ↗

No numbers read from the abstract.